References
- D.W.DicksonParkinson’s disease and parkinsonism: neuropathologyCold Spring Harb Perspect Med282012a00925
- S.FahnG.CohenThe oxidant stress hypothesis in Parkinson’sdisease: evidence supporting itAnn Neurol321992804812
- OnyouHwangRole of oxidative stress in parkinson's diseaseExp Neurobiol2220131117
- M.T.LinM.F.BealMitochondrial dysfunction and oxidative stress in neurodegenerative diseasesNature4432006787795
- A.H.SchapiraMitochondria in the aetiology and pathogenesis of Parkinson’s diseaseLancet Neurol7200897109
- S.J.ChintaJ.K.AndersenRedox imbalance in Parkinson’s diseaseBiochim Biophys Acta1780200813621367
- E.C.HirschS.HunotB.FaucheuxDopaminergic neuronsdegenerate by apoptosis in Parkinson’s diseaseMov Disord141999383385
- W.G.TattonC.W.OlanowApoptosis in neurodegenerative disease: the role of mitochondriaBiochim Biophys Acta14101999195213
- U.Ungerstedt6-Hydroxydopamine induced degeneration of central monoamine neuronsEur J Pharmacol51968107110
- Nicola simola, Micaela morreli and annar .cartaThe 6-Hydroxydopamine Model of Parkinson's DiseaseNeurotox Res112007151167
- D.BlumS.TorchN.LambengMolecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: Contribution to the apoptotic theory in Parkinson’s diseaseProg Neurobiol652001135172
- O.SalataApplications of nanoparticles in biology and medicineNanoBiotechnology220043
- T.PirmohamedJ.M.DowdingS.SinghNanoceria exhibit redox state-dependent catalase mimetic activityChem Commun (Camb)46201027362738
- E.G.HeckertA.S.KarakotiS.SealW.T.SelfThe role of ceriumredox state in the SOD mimetic activity of nanoceriaBiomaterials29200827052709
- L.KongX.CaiX.ZhouNanoceria extend photoreceptor cell lifespan in tubby mice by modulation of apoptosis/survival signaling pathwaysNeurobiol Dis422011514523
- X.ZhouL.L.WongA.S.KarakotiS.SealJ.F.Mc-GinnisNanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldlr knockoutmousePLoS One62011e16733
- N.PourkhaliliA.HosseiniA.Nili-AhmadabadiBiochemical and cellular evidence of the benefit of a combination of cerium oxide nanoparticles and selenium to diabetic rats. WorldJ Diabetes22011204210
- R.DavanR.G.S.V.PrasadV.S.JakkaCerium oxide nanoparticles promotes woundhealing activity in in-vivo animal modelJ Bionanosci620127883
- J.NiuK.WangP.KolattukudyCerium oxide nanoparticles inhibitsoxidative stress and nuclear factor-κb activation in H9c2cardiomyocytes exposed to cigarette smoke extractJ Pharmacol Exp Ther33820115361
- D.SchubertR.DarguschJ.RaitanoS.W.ChanCerium andyttrium oxide nanoparticles are neuroprotectiveBiochem Biophys Res Commun34220068691
- Michael P.SmithWayne A.CassOxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson’s diseaseNeuroscience144200710571066
- C.KimT.KimI.ChoiCeria Nanoparticles that can protect against Ischemic StrokeAngew Chem Int Ed5120121103911043
- G.PaxinosC.WatsonThe Rat Brain in Stereotaxic Coordinates4th ed.1998Academic PressSan Diego
- K.GuentherR.M.DeaconV.H.PerryJ.N.RawlinsEarly behavioural changes in scrapie-affected mice and the influence of dapsoneEur J Neurosci142001401409
- Y.S.AbadaH.P.NguyenR.SchreiberB.EllenbroekAssessment of motor function, sensory motor gating and recognition memory in a novel BACHD transgenic rat model for Huntington diseasePLoS One82013e68584
- M.OlssonG.NikkhahC.BentlageA.BjorklundForelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping testJ Neurosci155 Pt 2199538633875
- S.SpijkerDissection of rodent brain regionsW.K.LiNeuroproteomics2011Humana PressTotowa, NJ1326
- O.H.LowryN.J.RosebroughA.L.FarrR.J.RandallProtein measurement with the Folin phenol reagentJ Biol Chem1931951265275
- P.TripathiA.SinghS.AgrawalO.PrakashM.P.SinghCypermethrin alters the status of oxidative stress in the peripheral blood: relevance to ParkinsonismJ Physiol Biochem702014915924
- A.L.ArseneC.AramăN.MitreaA.N.CristeaExperimental assessment of cerebral monoaminergic status in a murine model of behaviorFarmacia572009492499
- D.KoracevicG.KoracevicV.DjordjevicS.AndrejevicV.CosicMethod for the measurement of antioxidant activity in human fluidsJ Clin Pathol542001356361
- E.D.WillsMechanisms of lipid peroxide formation in animal tissuesBiochem J991966667676
- H.A.MontgomeryJ.F.DymockThe determination of nitrite in waterAnalyst861961414416
- L.Casciola-RosenD.W.NicholsonT.ChongApopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic deathJ Exp Med183199619571964
- V.RizelioR.E.SzawkaL.L.XavierLesion of the subthalamic nucleus reverses motor deficits but not death of nigrostriatal dopaminergic neurons in a rat 6-hydroxydopamine-lesion model of Parkinson's diseaseBraz J Med Biol Res4320108595
- E.DowdC.MonvilleE.M.TorresS.B.DunnettThe corridor task: a simple test of lateralised response selection sensitive to unilateral dopamine deafferentation and graft-derived dopamine replacement in the striatumBrain Res Bull6820052430
- R.IancuP.MohapelP.BrundinG.PaulBehavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in miceBehav Brain Res1622005110
- T.SchallertD.NortonT.JonesA clinically relevant unilateral rat model of Parkinsonian akinesiaNeural Plast31992332333
- M.R.DeLongT.WichmannCircuits and circuit disorders of the basal gangliaArch Neurol6420072024
- U.AdigaJ.D’souzaR.KousalyaG.M.RaoM.NandiniV.D’souzaTotal antioxidant activity in Parkinson’s diseaseBiomed Res1722006145147
- R.LefterA.CiobicaL.HritcuB.StoicaD.CojocaruZ.OlteanuThe effects of a 6-OHDA induced lesion in murine nuccleus accumbens on memory and oxidative stress statusEur J Med82013443449
- M.T.MansouriY.FarboodM.J.SameriA.SarkakiB.NaghizadehM.RafeiradNeuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in ratsFood Chem138201310281033
- C.M.ChenJ.L.LiuY.R.WuIncreased oxidative damage in peripheral blood correlates with severity of Parkinson's diseaseNeurobiol Dis332009429435
- S.GuoJ.YanT.YangX.YangE.BezardB.ZhaoProtective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathwayBiol Psychiatry62200713531362
- Y.GlinkaM.GassenM.B.YoudimMechanism of 6-hydroxydopamine neurotoxicityJ Neural Transm Suppl19975566
- J.BovéC.PerierNeurotoxin-based models of Parkinson's diseaseNeuroscience20125176
- S.FahnD.SulzerNeurodegeneration and neuroprotection in Parkinson diseaseNeuroRx12004139154
- T.NagatsuM.SawadaMolecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cellsJ Neural Transm Suppl7120065365
- E.C.HirschS.HunotB.FaucheuxDopaminergic neurons degenerate by apoptosis in Parkinson’s diseaseMov Disord141999383385
- G.ChenK.A.BowerC.MaS.FangC.J.ThieleJ.LuoGlycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal deathFaseb J18200411621164
- E.E.OchuN.J.RothwellC.M.WatersCaspases mediate 6-hydroxydopamine-induced apoptosis but not necrosis in PC12 cellsJ Neurochem70199826372640
- N.TakaiH.NakanishiK.TanabeInvolvement of caspase-like proteinases in apoptosis of neuronal PC12 cells and primary cultured microglia induced by 6-hydroxydopamineJ Neurosci Res5421998214222
- R.W.TarnuzzerJ.ColonS.PatilS.SealVacancy engineered ceria nanostructures for protection from radiation-induced cellular damageNano Lett5200525732577
- K.L.HeckmanW.DeCoteauA.EstevezCustom cerium oxide nanoparticles protect against a free radical mediated autoimmune degenerative disease in the brainACS Nano720131058210596 (23)
- C.KimT.KimI.ChoiCeria Nanoparticles that can protect against ischemic strokeAngew Chem Int Ed5120121103911043
- N.SinghC.A.CohenB.A.RzigalinskiTreatment of neurodegenerative disorders with radical nanomedicineAnn N Y Acad Sci11222007219230
- T.PirmohamedJ.M.DowdingS.SinghNanoceria exhibit redox state-dependent catalase mimetic activityChem Commun (Camb)46201027362738
- J.C.YuL.ZhangJ.LinDirect sonochemical preparation of high-surface-area nanoporous ceria and ceria-zirconia solid solutionsJ Colloid Interface Sci2602003240243
- M.F.HochellaJrS.K.LowerP.A.MauriceNanominerals, mineral nanoparticles, and Earth systemsScience319200816311635
- A.KarakotiS.SinghJ.M.DowdingS.SealW.T.SelfRedox-active radical scavenging nanomaterialsChem Soc Rev39201044224432
- J.M.DowdingT.DosaniA.KumarS.SealW.T.SelfCerium oxide nanoparticles scavenge nitric oxide radical (NO)Chem Commun (Camb)48201248964898
- C.XuX.QuCerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applicationsNPG Asia Mater62014e90
- J.ColonN.HsiehA.FergusonCerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2Nanomedicine62010698705
- A.Y.EstevezS.PritchardK.HarperNeuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemiaFree Radic Biol Med51201111551163
- G.ChengW.GuoL.HanCerium oxide nanoparticles induce cytotoxicity in human hepatoma SMMC-7721 cells via oxidative stress and the activation of MAPK signaling pathwaysToxicol In Vitro27201310821088
- D.AliS.AlarifiS.AlkahtaniA.A.AlKahtaneA.AlmalikCerium oxide nanoparticles induce oxidative stress and genotoxicity in human skin melanoma cellsCell Biochem Biophys2014 (in Press)
- E.J.ParkJ.ChoiY.K.ParkK.ParkOxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cellsToxicology245200890100
- C.DillonM.BillingsK.HockeyL.DelagrazB.RzigalinskiCerium oxide nanoparticles protect against MPTP-induced dopaminergic neurodegeneration in a mouse model for parkinson's diseaseNanotechnology32011451454